Quantum-Si Incorporated (Nasdaq: QSI) is a life sciences semiconductor company developing chip-based platforms for next-generation protein sequencing. The company entered the public markets through a business combination with GX Acquisition Corp. II, a blank-check company sponsored by GX Capital that completed its IPO in 2020. A Form 10-Q filed November 13, 2020, under accession number 0001104659-20-124503 reflects a quarterly disclosure from the SPAC entity during its pre-combination operating period. The business combination subsequently closed in 2021, and QSI now trades on the Nasdaq within the life sciences and genomics sector. For the full filing timeline and comprehensive SPAC analytics on QSI, sign up for complete data access at SpacDesk.